methotrexate has been researched along with Cancer of Muscle in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 8 (42.11) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Hinotsu, S; Kitamura, H; Kobayashi, T; Kojima, T; Miyake, M; Mizusawa, J; Nishiyama, H; Nishiyama, N; Shibata, T; Tsukamoto, T | 1 |
| Campbell, M; Czerniak, BA; Dinney, C; Ferguson, JE; Guo, CC; Kamat, AM; Li, R; McConkey, DJ; Metcalfe, MJ; Navai, N; Pretzsch, SM; Siefker-Radtke, A; Xiao, L | 1 |
| Baggerly, K; Bondaruk, J; Cheng, T; Choi, W; Czerniak, B; Dinney, CP; Hoffman-Censits, J; Kim, S; Lee, IL; Majewski, T; McConkey, DJ; Melquist, J; Plimack, ER; Porten, S; Pretzsch, S; Roth, B; Siefker-Radtke, A; Tran, M; Willis, D; Zhang, S | 1 |
| Agarwal, N; Bellmunt, J; Berthold, D; Chowdhury, S; Crabb, SJ; Galsky, MD; Harshman, LC; Hussain, SA; Ladoire, S; Milowsky, MI; Moshier, EL; Necchi, A; Pal, SK; Powles, T; Recine, F; Rosenberg, JE; Theodore, C; Vaishampayan, UN; Wong, YN; Yu, EY | 1 |
| Campbell, SC; Dreicer, R; Fergany, AF; Garcia, JA; Gong, MC; Hansel, DE; Jones, JS; Klein, EA; Stephenson, AJ; Weight, CJ | 1 |
| Griffiths, G; Hall, R; Parmar, MK; Raghavan, D; Sylvester, R | 1 |
| Kaneko, G; Kikuchi, E; Matsumoto, K; Miyajima, A; Nakamura, S; Obata, J; Oya, M | 1 |
| Caccuri, A; Fanelli, M; Hattinger, CM; Landuzzi, L; Lollini, PL; Manara, MC; Michelacci, F; Nicoletti, G; Pasello, M; Picci, P; Scotlandi, K; Serra, M | 1 |
| Al-Terkait, F; Blick, C; Chester, JD; Crew, J; Douglas, D; Hall, P; Kilbey, N; Macaulay, V; Munro, N; Powles, T; Protheroe, A; Pwint, T | 1 |
| Bertouch, JV; Lim, IG | 1 |
| Gandhi, MM; Levitt, GA; Nathan, PC; Weitzman, S | 1 |
| SEELEN, JC | 1 |
| EVERS, JE; SEELEN, JC | 1 |
| Griffiths, TR; Kriajevska, M; McHugh, LA; Mellon, JK; Symonds, RP | 1 |
| Baker, LH; Crawford, ED; Faulkner, J; Higano, CS; Hussain, M; Meyers, FJ; Rivkin, SE; Russell, KJ; Sakr, WA; Tangen, CM | 1 |
| Chadha, M; Grabstald, H; Hecht, H; Malamud, SC; Vikram, B | 1 |
| Bagiella, E; Benson, MC; Ennis, RD; O'Toole, KM; Olsson, CA; Petrylak, DP; Singh, P | 1 |
| Dinney, CP; Inoue, K; Karashima, T; Millikan, R; Shuin, T; Slaton, JW; Sweeney, P; Yoshikawa, C | 1 |
| Cohen, EE; Stadler, WM | 1 |
3 review(s) available for methotrexate and Cancer of Muscle
| Article | Year |
|---|---|
Successful treatment of life-threatening generalized infantile myofibromatosis using low-dose chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Critical Care; Dactinomycin; Female; Humans; Infant, Newborn; Male; Methotrexate; Muscle Neoplasms; Myofibromatosis; Osteolysis; Prednisolone; Remission Induction; Respiration, Artificial; Skin Neoplasms; Soft Tissue Neoplasms; Vinblastine; Vincristine | 2003 |
Tyrosine kinase inhibitors of the epidermal growth factor receptor as adjuncts to systemic chemotherapy for muscle-invasive bladder cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Doxorubicin; Enzyme Inhibitors; ErbB Receptors; Gefitinib; Genes, erbB-1; Humans; Methotrexate; Muscle Neoplasms; Neoadjuvant Therapy; Oncogene Proteins v-erbB; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quinazolines; Receptor Protein-Tyrosine Kinases; Receptor, ErbB-2; Urinary Bladder Neoplasms; Vinblastine | 2004 |
Treatment of metastatic urothelial cancer in the post-MVAC era.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Methotrexate; Muscle Neoplasms; Urinary Bladder Neoplasms; Urothelium; Vinblastine | 2001 |
4 trial(s) available for methotrexate and Cancer of Muscle
| Article | Year |
|---|---|
Effect of neoadjuvant chemotherapy on health-related quality of life in patients with muscle-invasive bladder cancer: results from JCOG0209, a randomized phase III study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystectomy; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Muscle Neoplasms; Neoadjuvant Therapy; Quality of Life; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2020 |
Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blotting, Western; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Differentiation; Cell Proliferation; Cisplatin; Clinical Trials, Phase II as Topic; Cohort Studies; Doxorubicin; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Humans; Male; Methotrexate; MicroRNAs; Muscle Neoplasms; Mutation; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; PPAR gamma; Prognosis; Real-Time Polymerase Chain Reaction; Receptor, Fibroblast Growth Factor, Type 3; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms; Vinblastine | 2014 |
International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Female; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Muscle Neoplasms; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Urinary Bladder Neoplasms; Vinblastine | 2011 |
Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Muscle Neoplasms; Neoplasm Invasiveness; Pilot Projects; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 1998 |
12 other study(ies) available for methotrexate and Cancer of Muscle
| Article | Year |
|---|---|
Impact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle Invasion.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Disease-Free Survival; Doxorubicin; Female; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Mucous Membrane; Muscle Neoplasms; Neoplasm Invasiveness; Preoperative Care; Risk Factors; Urinary Bladder Neoplasms; Vinblastine | 2017 |
Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Muscle Neoplasms; Neoadjuvant Therapy; Neoplasm Invasiveness; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2015 |
Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Combined Modality Therapy; Cystectomy; Deoxycytidine; Doxorubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Maximum Tolerated Dose; Methotrexate; Middle Aged; Muscle Neoplasms; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Risk Factors; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2009 |
Neoadjuvant gemcitabine plus cisplatin for muscle-invasive bladder cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystectomy; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Muscle Neoplasms; Muscle, Smooth; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2011 |
Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glutathione Transferase; Humans; Isoenzymes; Methotrexate; Mice; Mice, Nude; Muscle Neoplasms; Muscle, Skeletal; Oxadiazoles; Sarcoma; Time Factors; Tumor Burden; Vincristine; Xenograft Model Antitumor Assays | 2011 |
Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Muscle Neoplasms; Neoadjuvant Therapy; Neoplasm Invasiveness; Recurrence; Retrospective Studies; Urinary Bladder Neoplasms; Vinblastine | 2012 |
Remission of lymphoma after drug withdrawal in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Buttocks; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Muscle Neoplasms; Muscle, Skeletal; Remission, Spontaneous | 2002 |
[TREATMENT OF UTERINE SARCOMA WITH METHOTREXATE].
Topics: Drug Therapy; Female; Humans; Methotrexate; Muscle Neoplasms; Neoplasms; Sarcoma; Uterine Neoplasms | 1964 |
[TREATMENT OF UTERINE SARCOMA WITH METHOTREXATE].
Topics: Drug Therapy; Female; Humans; Methotrexate; Muscle Neoplasms; Myosarcoma; Sarcoma; Uterine Neoplasms | 1965 |
Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Muscle Neoplasms; Neoadjuvant Therapy; Prognosis; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2008 |
The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cystectomy; Disease-Free Survival; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Muscle Neoplasms; Muscle, Smooth; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Risk Factors; Treatment Failure; Urinary Bladder Neoplasms; Vinblastine | 2000 |
The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy.
Topics: Adult; Aged; Angiogenesis Inducing Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Disease-Free Survival; Doxorubicin; Endothelial Growth Factors; Female; Fibroblast Growth Factor 2; Humans; Immunohistochemistry; In Situ Hybridization; Interleukin-8; Lymphokines; Male; Methotrexate; Microcirculation; Middle Aged; Multivariate Analysis; Muscle Neoplasms; Neoplasm Metastasis; Prognosis; Recurrence; RNA, Messenger; Time Factors; Urinary Bladder Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vinblastine | 2000 |